Influence of comorbidity on chemotherapy use for early breast cancer: systematic review and meta-analysis

[1] Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108

[2] Bray F(1996)Assessing the impact of comorbidity in the older population Ann Epidemiol 6 376-380

[3] Siegel RL(2009)Future of cancer incidence in the United States: burdens upon an aging, changing nation J Clin Oncol 27 2758-2765

[4] Ferlay J(2005)Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 1687-1717

[5] Lortet-Tieulent J(2015)Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Ann Oncol 26 1533-1546

[6] Jemal A(2003)Participation of patients 65 years of age or older in cancer clinical trials J Clin Oncol 21 1383-1389

[7] Guralnik JM(2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Int Med 151 264-270

[8] Smith BD(1994)The effect of comorbidity on 3-year survival of women with primary breast cancer Ann Intern Med 120 104-110

[9] Smith GL(2007)Disentangling the effects of race on breast cancer treatment Cancer 110 2169-2177

[10] Hurria A(2012)Anthracycline regimen adherence in older patients with early breast cancer Oncologist 17 303-311

[1] Torre LA(2015)Global cancer statistics, 2012 CA Cancer J Clin 65 87-108

[2] Bray F(1996)Assessing the impact of comorbidity in the older population Ann Epidemiol 6 376-380

[3] Siegel RL(2009)Future of cancer incidence in the United States: burdens upon an aging, changing nation J Clin Oncol 27 2758-2765

[4] Ferlay J(2005)Effects of chemotherapy and hormonal therapy for early breast cancer on recurrence and 15-year survival: an overview of the randomised trials Lancet 365 1687-1717

[5] Lortet-Tieulent J(2015)Tailoring therapies—improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015 Ann Oncol 26 1533-1546

[6] Jemal A(2003)Participation of patients 65 years of age or older in cancer clinical trials J Clin Oncol 21 1383-1389

[7] Guralnik JM(2009)Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement Ann Int Med 151 264-270

[8] Smith BD(1994)The effect of comorbidity on 3-year survival of women with primary breast cancer Ann Intern Med 120 104-110

[9] Smith GL(2007)Disentangling the effects of race on breast cancer treatment Cancer 110 2169-2177

[10] Hurria A(2012)Anthracycline regimen adherence in older patients with early breast cancer Oncologist 17 303-311